GlobeNewswire - Industry News on Drug Retailers

Rocky Mountain High Brands Gives Update on Form 10-Q Filings

Wed, 24 Feb 2021 14:00 GMT

PLANO, Texas, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc., announced today that due to the number of inquiries regarding the quarterly financials of the Company (OTCPK: RMHB), it is providing the following information and update.

TILT Holdings Announces Participation In Upcoming Conferences

Tue, 23 Feb 2021 18:31 GMT

PHOENIX, Feb. 23, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a provider of business solutions to the global cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced that its leadership team will participate in the following upcoming conferences:

TILT Holdings, Inc. Announces Assignment of Ermont, Inc.?Note Receivable

Mon, 22 Feb 2021 22:47 GMT

PHOENIX, Feb. 22, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a provider of business solutions to the global cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced the assignment by its subsidiary, SH Finance Company, LLC, of the Loan and Security Agreement entered into with Ermont, Inc. (the “Ermont Note”) to Teneo Funds SPVi LLC, through an arm’s-length third-party transaction, in exchange for $1,250,000 in cash and a portion of future collections pursuant to the Ermont Note. The assignment agreement contains standard representations, warranties and indemnifications between the parties.

MATEON THERAPEUTICS AND WINDLAS BIOTECH LAUNCH INDIA’S FIRST COMBINED LUNG THERAPY AND AI TELEMEDICINE 360° SOLUTION TO TRANSFORM RESPIRATORY WELLNESS AT WWW.PULMOHEAL.COM

Mon, 22 Feb 2021 12:00 GMT

AGOURA HILLS, California, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health and Windlas Biotech Pvt. Ltd. (Windlas), a leading Indian pharmaceutical contract drug development and manufacturing organization, announced today the launch in India of PulmoHeal^??a first-of-its-kind integrated, consumer-centric solution for respiratory wellness.

TILT Holdings Strengthens Compliance Team, Welcoming Nicole Moyers as Vice President of Compliance and Patrick Beyea as Director of Compliance

Thu, 18 Feb 2021 12:00 GMT

Ms. Moyers served on the Pennsylvania Cannabis Coalition; Mr. Beyea served on the Massachusetts Cannabis Control Commission

Minor Cannabinoids Take Center Stage in New Suite of Consumer-friendly OTC Supplement Tablets

Wed, 17 Feb 2021 13:00 GMT

Volunteer Botanicals’ ‘flowable powders’ enable line of compounded cannabinoids in oil-free, fast-acting tablets from Hempleton Investment Group

Volunteer Botanicals’ ‘flowable powders’ enable line of compounded cannabinoids in oil-free, fast-acting tablets from Hempleton Investment Group

TILT Holdings Provides Preliminary Fourth Quarter Results, Operational Highlights and 2021 Outlook

Wed, 17 Feb 2021 11:30 GMT

Jupiter Q4 2020 revenues return to pre-COVID levels

MATEON PARTNERED WITH CHOPRA FOUNDATION ON ARTIVEDA?

Tue, 16 Feb 2021 14:52 GMT

AGOURA HILLS, California, Feb. 16, 2021 (GLOBE NEWSWIRE) -- ?Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health, announced a global partnership with Chopra Foundation, a non-profit, to collaborate on research and development of PulmoHeal^? and ARTIVeda^? for COVID-19 and other infectious diseases through joint research between Mateon and Foundation Principal Investigators (PI) from premium US universities.

TILT Holdings Inc. Congratulates Partner, Kanabo Group PLC, on?Commencing Trading on the London Stock Exchange

Tue, 16 Feb 2021 12:30 GMT

Kanabo Now the First Medical Cannabis IPO to Be Listed on the LSE

Kanabo Now the First Medical Cannabis IPO to Be Listed on the LSE

The Flowr Corporation Announces Equity Grant

Sat, 13 Feb 2021 02:21 GMT

TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) announces the granting of incentive stock options to purchase 6,496,000 common shares in the capital of the Company (the “Options”) and 2,970,000 restricted share units (the “RSUs”) to certain employees, officers and directors of the Company, subject to regulatory approval.? The Options and RSUs were granted on February 8, 2021 pursuant to the Company’s applicable incentive plans. The Options are exercisable at a price of?$0.44?per share and are set to expire on?February 12, 2026.? The Options and RSUs vest as follow: (a)?one-third on the first anniversary of when the Options and RSUs were granted; (b) one-third on the second anniversary of when the Options and RSUs were granted; and (c) the remaining one-third on the third anniversary of when the Options and RSUs were granted. Notwithstanding the foregoing, 2,106,949 RSUs shall vest immediately and are subject to certain vesting periods.

The Flowr Corporation Announces Increase to Bought Deal Public Offering to $15 million

Thu, 11 Feb 2021 17:01 GMT

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Delta 9 Provides Guidance & Timing for Year End 2020 Results

Wed, 10 Feb 2021 23:00 GMT

WINNIPEG, Manitoba, Feb. 10, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) ("Delta 9" or the "Company"), is pleased to provide guidance on select fourth quarter and year end results ending December 31, 2020 based on preliminary results:

The Flowr Corporation Announces $10 Million Bought Deal Public Offering

Wed, 10 Feb 2021 21:31 GMT

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Zenabis Announces the Establishment of an At-the-Market Equity Offering Program

Wed, 10 Feb 2021 03:14 GMT

VANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today announced that it has established an at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$15,000,000 of common shares in the capital of the Company (the “Common Shares”) from treasury to the public from time to time, at the Company’s discretion. Any Common Shares sold through the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”) or any other marketplace on which the Common Shares are listed, quoted or otherwise traded, at the prevailing market price at the time of sale.

Delta 9 Partner Oceanic Releaf Receives Health Canada Licence for Cannabis Production

Tue, 09 Feb 2021 23:00 GMT

BURIN, Newfoundland and Labrador, Feb. 09, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”) is pleased to announce its strategic partner Oceanic Releaf Inc. (“Oceanic”) has been granted its cannabis cultivation licenses from Health Canada (the “Health Canada License”) for standard cannabis and processing operations. Delta 9 owns a 5% equity stake in Oceanic’s production facility operations and retail store and has a 20-year supply agreement with Oceanic and the Government of Newfoundland and Labrador.

Delta 9 to Open Tenth Cannabis Retail Store

Fri, 05 Feb 2021 12:00 GMT

WINNIPEG, Manitoba, Feb. 05, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce the grand opening of its tenth Delta 9 Cannabis retail store, and seventh cannabis store in the Province of Manitoba. Delta 9’s newest retail store is located in the City of Winnipeg and is scheduled to open on February 5, 2021.

TILT Holdings Inc. Announces Exclusive Contract to Manufacture and Distribute Her Highness NYC Branded Products in Massachusetts

Thu, 04 Feb 2021 12:30 GMT

Dedicated to Delivering Experiences that Elevate and Celebrate Women, Her Highness NYC is a Female-Owned, Premium Cannabis Brand with a Portfolio of Products Inspired and Engineered by Women for Women

Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner

Thu, 04 Feb 2021 12:00 GMT

WINNIPEG, Manitoba, Feb. 04, 2021 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) ("Delta 9" or the "Company"), is pleased to announce that it has completed its final services milestone under an agreement with Alberta based Micro Cultivation partner, Dry Island LTD. (“Dry Island”). Dry Island is an arm’s length third party in which the Company has no ownership control or interest.

The Flowr Corporation Announces Entry into Quebec

Thu, 04 Feb 2021 11:00 GMT

Highlights:

Flowr Corporation annonce son entrée au Québec

Thu, 04 Feb 2021 11:00 GMT

Faits marquants